+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
Overactive Bladder Treatment Global Market Report 2024 - Product Thumbnail Image

Overactive Bladder Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 179 Pages
  • Global
From
Vitiligo Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Vitiligo Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
From
From
From
From
From
From
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • September 2024
  • 250 Days
  • Global
From
Pediatric Neuroblastoma Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Urinary Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Loading Indicator